Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of ATX-101 versus placebo for reduction of submental fat
2010-020691-28Phase 3Completed
- Sponsor
- Kythera Biopharmaceuticals
- Start
- Aug 2010
- Modality
- Small Molecules, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ATX101 in submental fat and Submental lipomatosis (3 arms), sponsored by Kythera Biopharmaceuticals. Started Aug 2010; status: completed.
02
Drugs
ATX101
03
Conditions
submental fatSubmental lipomatosis
Beyond the preview
Go deeper on 2010-020691-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020691-28.